Regional citrate anticoagulation in continuous venovenous haemodiafiltration using commercial solutions

Nephrology Dialysis Transplantation

Volumn 19, Issue 1, 2004, Pages 171-178

  Cointault, Olivier ^a   Kamar, Nassim ^a   Bories, Pierre ^a   Lavayssiere, Laurence ^a   Angles, Olivier ^b   Rostaing, Lionel ^a   Genestal, Michèle ^b   Durand, Dominique ^a  

^a CHU RANGUEIL   (France)

^b CHU PURPAN   (France)

Author keywords

Bleeding complications; Citrate; Commercial solutions; Critically ill patients; Haemodiafiltration; Regional anticoagulation

Indexed keywords

A.C.D A; CALCIUM CHLORIDE; CALCIUM ION; CITRATE DISODIUM; HEPARIN;

ACID BASE BALANCE; ACUTE KIDNEY FAILURE; ADULT; AGED; ANTICOAGULATION; ARTICLE; ARTIFICIAL KIDNEY; BLEEDING; BLEEDING TENDENCY; BLOOD CLOTTING; CALCIUM BLOOD LEVEL; CARDIOGENIC SHOCK; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; CRITICAL ILLNESS; DRUG COST; DRUG EFFICACY; DRUG SAFETY; ENDOCARDITIS; FEMALE; FILTER; FLOW RATE; HEART DISEASE; HEMATOLOGICAL PARAMETERS; HEMODIALYSIS; HEMORRHAGIC SHOCK; HUMAN; HYPERNATREMIA; HYPOCALCEMIA; LUNG ABSCESS; MALE; METABOLIC ALKALOSIS; NEUROMUSCULAR DISEASE; PANCREATITIS; PATIENT MONITORING; PERITONITIS; PRIORITY JOURNAL; RESPIRATORY DISTRESS; RHABDOMYOLYSIS; SEPTIC SHOCK;

ADULT; AGED; ANTICOAGULANTS; BLOOD COAGULATION; BLOOD COAGULATION DISORDERS; CALCIUM; CATIONS, DIVALENT; CITRATES; COSTS AND COST ANALYSIS; CRITICAL ILLNESS; DIALYSIS SOLUTIONS; FEASIBILITY STUDIES; FEMALE; HEMODIAFILTRATION; HEMOFILTRATION; HUMANS; KIDNEY FAILURE, ACUTE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0347286846     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfg488     Document Type: Article

References (30)

1. Bellomo R, Ronco C. Continuous versus intermittent renal replacement therapy in intensive care unit. Kidney Int 1998; 53 [Suppl 66): S125-S128
2. Ronco C, Bellomo, R, Homel P et al. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet 2000; 356: 26-30
3. van de Wetering J, Westendorp RG, van der Hoeven JG et al. Heparin use in continuous renal replacement procedures: the struggle between filter coagulation and patient hemorrhage. J Am Soc Nephrol 1996; 7: 145-150
4. Ward DM, Mehta RL. Extracorporeal management of acute renal failure patients at high risk of bleeding. Kidney Int Suppl 1993; 41: S237-S244
5. Davenport A. The coagulation system in the critically ill patient with acute renal failure and the effect of an extracorporeal circuit. Am J Kidney Dis 1997; 30: S20-S27
6. Ballard JO. Anticoagulant-induced thrombosis. JAMA 1999; 282: 310-312
7. Warkentin TE, Levine MN, Hirsh J et al. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med 1995; 332: 1330-1335
8. Kaplan AA, Petrillo R. Regional heparinization for continuous arterio-venous hemofiltration (CAVH). ASAIO Trans 1987; 33: 312-315
9. Jeffrey RF, Khan AA, Douglas JT, Will EJ, Davison AM. Anticoagulation with low molecular weight heparin (Fragmin) during continuous hemodialysis in the intensive care unit. Artif Organs 1993; 17: 717-720
10. Reeves JH, Cumming AR, Gallagher L, O'Brien JL, Santamaria JD. A controlled trial of low-molecular-weight heparin (dalteparin) versus unfractionated heparin as anti-coagulant during continuous venovenous hemodialysis with filtration. Crit Care Med 1999; 27: 2224-2228
11. Paganini EP. Slow continuous hemofiltration and slow continuous ultrafiltration. ASAIO Trans 1988; 34: 63-66
12. Kozek-Langenecker SA, Kettner SC, Oismueller C et al. Anticoagulation with prostaglandin E1 and unfractionated heparin during continuous venovenous hemofiltration. Crit Care Med 1998; 26: 1208-1212
13. Ponikvar R, Kandus A, Buturovic J, Kveder R. Use of prostacyclin as the only anticoagulant during continuous venovenous hemofiltration. Contrib Nephrol 1991; 93: 218-220
14. Ohtake Y, Hirasawa H, Sugai T et al. Nafamostat mesylate as anticoagulant in continuous hemofiltration and continuous hemodialiltration. Contrib Nephrol 1991; 93: 215-217
15. Vargas Hein O, von Heymann C, Lipps M et al. Hirudin versus heparin for anticoagulation in continuous renal replacement therapy. Intensive Care Med 2001; 27: 673-679
16. Mehta RL, McDonald BR, Aguilar MM, Ward DM. Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients. Kidney Int 1990; 38: 976-981
17. Palsson R, Niles JL. Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleeding. Kidney Int 1999; 55: 1991-1997
18. Kutsogiannis DJ, Mayers I, Chin WD, Gibney RT. Regional citrate anticoagulation in continuous venovenous hemodiafiltration. Am J Kidney Dis 2000; 35: 802-811
19. Tolwani AJ, Campbell RC, Schenk MB, Allon M, Warnock DG. Simplified citrate anticoagulation for continuous renal replacement therapy. Kidney Int 2001; 60: 370-374
20. Hofmann RM, Maloney C, Ward DM, Becker BN. A novel method for regional citrate anticoagulation in continuous venovenous hemofiltration (CVVHF). Ren Fail 2002; 24: 325-335
21. Gabutti L, Marone C, Colucci G, Duchini F, Schonholzer C. Citrate anticoagulation in continuous venovenous hemodiafiltration: a metabolic challenge. Intensive Care Med 2002; 28: 1419-1425
22. le Gall JR, Lemeshow S, Saulnier F. A new simplified acute physiology score (SAPS II) based on a European/North American multicenter study. JAMA 1993; 270: 2957-2963
23. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481
24. Bellomo R, Teede H, Boyce N. Anticoagulant regimens in acute continuous hemodiafiltration: a comparative study. Intensive Care Med 1993; 19: 329-332
25. Tan HK, Baldwin I, Bellomo R. Continuous veno-venous hemofiltration without anticoagulation in high-risk patients. Intensive Care Med 2000; 26: 1652-1657
26. Davenport A, Will EJ, Davison AM. Comparison of the use of standard heparin and prostacyclin anticoagulation in spontaneous and pump-driven extracorporeal circuits in patients with combined acute renal and hepatic failure. Nephron 1994; 66: 431-437
27. Martin PY, Chevrolet JC, Suter P, Favre H. Anticoagulation in patients treated by continuous venovenous hemofiltration: a retrospective study. Am J Kidney Dis 1994; 24: 806-812
28. Hofbauer R, Moser D, Frass M et al. Effect of anticoagulation on blood membrane interactions during hemodialysis. Kidney Int 1999; 56: 1578-1583
29. Flannigan MJ, von Brecht J, Freeman RM, Lim VS. Reducing the hemorrhagic complications of hemodialysis: a controlled comparison of low-dose heparin and citrate anticoagulation. Am J Kidney Dis 1987; 9: 147-153
30. Zivin JR, Gooley T, Zager RA, Ryan MJ. Hypocalcemia: a pervasive metabolic abnormality in the critically ill. Am J Kidney Dis 2001; 37: 689-698